Log in
Enquire now
‌

US Patent 12121574 Malaria immunogen and methods for using same

OverviewStructured DataIssuesContributors

Contents

Patent abstractTimelineTable: Further ResourcesReferences
Is a
Patent
Patent
1

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
121215741
Patent Inventor Names
Bryce C. Chackerian1
Nikolai Petrovsky1
David S. Peabody1
Fidel P. Zavala1
Lucie Jelinkova1
Date of Patent
October 22, 2024
1
Patent Application Number
179537121
Date Filed
September 27, 2022
1
Patent Citations
‌
US Patent 7957913 Evaluating genetic disorders
1
‌
US Patent 9012208 Nucleic acid purification
1
‌
US Patent 7776616 Apparatuses and methods for isolating nucleic acid
1
Patent Primary Examiner
‌
Jennifer E. Graser
1
Patent abstract

An immunogen useful for treating malaria generally includes an immunogenic carrier and an antigenic malaria circumsporozoite protein (CSP) peptide that includes the peptide NANPNVDPNANPNVD (SEQ ID NO:2) linked to the immunogenic carrier. The immunogen may be administered to a subject having or at risk of having malaria. Alternatively, the immunogen may be administered to an individual having or at risk of having

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 12121574 Malaria immunogen and methods for using same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.